RESEARCH USE ONLY. Reference data for laboratory research. Not medical advice; not for human consumption.
Peptijournal
Calc

Compare compounds

Pick up to 3 compounds to see protocols, mechanisms, study endpoints and safety findings side by side.

PopularRetatrutide vs TirzepatideSemaglutide vs TirzepatideSemaglutide vs RetatrutideBPC-157 vs TB-500BPC-157 vs GHK-CuSermorelin vs Tesamorelin
Selank
Same goal
Include when printing

Only affects the printed page / PDF. The research-use-only notice always prints.

Protocol01
Selank

Cognitive

Vials · 5 / 10 mg

01Protocol

Start
0.25 mg
Range
0.25–0.5 mg
Frequency
1–2× daily
Cycle
2–4 weeks
Vials
5 / 10 mg

02Quick calculator

Draw (100u)

—

Concentration

—

mg/mL

03Mechanism of action

Selank is a synthetic analog of tuftsin (an immune-related tetrapeptide) with an added Pro-Gly-Pro sequence for stability. It is studied for effects on enkephalin breakdown and GABAergic gene expression.

04Study endpoints

  • In 62 patients with generalised anxiety disorder or neurasthenia, Selank's anti-anxiety effect was similar to medazepam's.
  • That trial also reported anti-fatigue and stimulant-like effects, and higher blood enkephalin activity during treatment.
  • Cell studies report changes in the expression of genes involved in GABA signalling.

05Safety & regulatory findings

  • Registered as a medicine in Russia; not approved by the FDA or EMA.
  • The main clinical data is small and Russian-language.

06Citations

2 references · view